Submitted by Anonymous (not verified) on 30 August 2023 - 15:17
Opinion/decision on a Paediatric investigation plan (PIP): bimekizumab, decision type: , therapeutic area: , PIP number: P/0339/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): bimekizumab, decision type: , therapeutic area: , PIP number: P/0339/2022